Indaptus Therapeutics News

Indaptus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Dec 23 16:57 ET

Indaptus Therapeutics | D: Filing D

Dec 6 16:40 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A

Nov 26 16:19 ET

Indaptus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeffrey A. Meckler(6.9%)

Nov 26 16:13 ET

Indaptus Therapeutics | 8-K: Current report

Nov 22 16:51 ET

Indaptus Therapeutics | 424B5: Prospectus

Nov 22 16:26 ET

Indaptus Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 11:41 ET

Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 09:40 ET

Indaptus Therapeutics | 8-K: Current report

Oct 22 08:08 ET

Indaptus Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Jeffrey A. Meckler(7.3%)

Oct 10 16:15 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Newman Michael James

Oct 10 16:10 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Linscott Walt Addison

Oct 10 16:10 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A

Oct 10 16:10 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.

Oct 10 16:05 ET

Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sassi Nir

Oct 10 16:05 ET

Indaptus Therapeutics | D/A: Filing D (Amendment)

Oct 4 17:25 ET

Indaptus Therapeutics | EFFECT: Others

Sep 23 06:03 ET

Indaptus Therapeutics | CORRESP: CORRESP

Sep 18 13:13 ET

Indaptus Therapeutics | UPLOAD: Others

Sep 17 13:13 ET

Indaptus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Sep 12 16:49 ET